PCSK9 and hepatocellular carcinoma: Using HepG2 cells for subcutaneous transplantation and luci‐Hepa1‐6 cells for orthotopic liver injection, researchers found that high PCSK9 expression negatively correlated with overall survival and CD8+ T cell markers in HCC patients.